CALC CalciMedica, Inc.
Company Analysis
Latest News
🟢 CalciMedica is trading 8.6% up today as it rebounds from a sharp sell-off following its FDA-driven rally
CalciMedica is trading at $0.81 (8.6% up) in after-hours as it partially rebounds from a sharp 25.7% drop during the August 3 regular session. • The move...
🔴 CalciMedica is trading 20% down today on profit-taking after FDA-driven rally
CalciMedica is trading at approximately $0.80 (20% down) as investors lock in gains following a sharp two-session rally tied to regulatory optimism. - The...
🔴 CalciMedica is trading 7.2% down today after pulling back from its recent FDA-driven rally
CalciMedica is trading at $0.93 (-7.22%) today as the stock pulls back from a recent rally fueled by FDA trial-alignment optimism. • The decline follows a...
🔴 CalciMedica is trading 5% down today as it pulls back from a multi-day rally following FDA trial alignment
CalciMedica is trading at $0.95 (5% down) in after-hours trading, pulling back slightly after a sharp multi-day rebound. • The recent upside was driven by FDA...
🟢 CalciMedica is trading 10.3% up today as rebound continues after FDA alignment on Phase 2b trial
CalciMedica is trading at $0.93 (up 10.3%), extending a sharp multi-day rebound that followed positive regulatory news regarding its lead clinical program. •...
🟢 CalciMedica is trading 6.2% up today as FDA trial alignment extends multi-day rebound
CalciMedica is trading at $0.89 (6.2% up), extending a multi-day rebound following FDA alignment on the design and endpoints for its planned Phase 2b trial in...
CalciMedica Gets FDA Nod on Trial Design — But Can a $15 Million Micro-Cap Actually Run the Race?
Shares of CalciMedica surged 11.1% to $0.83 on July 29 after the company announced the FDA had aligned with it on the design and endpoint for a planned Phase...
🟢 CalciMedica is trading 11.1% up today after FDA alignment on Phase 2b trial design for Auxora
CalciMedica is trading 11.1% up today at $0.83 after the FDA aligned with the company on the Phase 2b trial design for its Auxora therapy in acute...
🟢 CalciMedica is trading 5.04% up today after FDA alignment on Phase 2b Auxora trial design
CalciMedica is trading at $0.78 (+5.04%) after the FDA aligned with the company on its Phase 2b Auxora trial design for acute pancreatitis. • The trial...
🟢 CalciMedica Surges 5.7% After FDA Alignment on Phase 2b Auxora Trial Design
• CalciMedica's stock is up 5.7% to $0.76 following news of the U.S. Food and Drug Administration (FDA) aligning on the Phase 2b trial design for its lead...
🟢 CalciMedica is trading 5.2% up today on technical trading and sentiment
CalciMedica is trading 5.2% up at $0.75 today, with the move appearing to be driven by technical trading and sentiment rather than new fundamental news. -...
🟢 CalciMedica is trading 5.9% up today with no clear catalyst
CalciMedica is trading at $0.76, up 5.9% in after-hours trading with no clear fundamental catalyst, after closing the regular session at $0.72. • No new...
🟢 CalciMedica is trading 5.4% up today, partially reversing yesterday's losses
CalciMedica is trading 5.4% up today at $0.74, recovering a portion of yesterday’s 7.5% drop amid continued volatility. • The move appears to be technical or...
🔴 CalciMedica is trading 5.8% down today with no clear catalyst identified
CalciMedica is trading at $0.72 (down 5.8%) with no fresh company-specific news or fundamental catalysts explaining today's move. • The decline follows a...
🟢 CalciMedica is trading 6.2% up today with no clear catalyst identified
CalciMedica is trading 6.2% up at $0.76 today with no clear company-specific catalyst identified to drive the price action. • There are no fresh SEC filings,...
🔴 CalciMedica is trading 5% down today with no clear catalyst identified
CalciMedica is trading 5% down today at $0.68 with no clear catalyst identified following a week of significant price swings. • No new SEC filings, press...
🟢 CalciMedica is trading 6.8% up today amid speculative small-cap trading
CalciMedica is trading at $0.76 (+6.80%) in pre-market following a quiet session with no company-specific catalyst identified from available news. • The move...
🟢 CalciMedica is trading 10.5% up
CalciMedica is trading at $0.78, up 10.5% from a comparison close of $0.71 during regular trading. This is a price-action follow-up, so a separate catalyst may...
🟢 CalciMedica is trading 6.46% up today with no clear company-specific catalyst found
CalciMedica is trading at $0.75 (+6.46%) in pre-market with no clear company-specific catalyst found following its close at $0.70 on July 20, 2026. • The move...
🔴 CalciMedica is trading 5.7% down today as it digests trial and delisting news
CalciMedica is trading 5.7% down today at $0.69 as the stock continues to digest the impact of recent negative developments and trial setbacks. • The stock...